Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - dextromethorphan hydrobromide 1,5 mg/ml - oral solution - 1,5 mg/ml - dextromethorphan hydrobromide 1.5 mg/ml - dextromethorphan

Filipiinid - inglise - FDA (Food And Drug Administration)

yunimedika philippines, inc. - paracetamol / phenylpropanolamine hcl / chlorpheniramine maleate / dextromethorphan hbr - capsule - 325mg/ 10mg/ 1mg/ 15mg

Filipiinid - inglise - FDA (Food And Drug Administration)

n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - paracetamol , guaifenesin , phenylpropanolamine hydrochloride , dextromethorphan hydrobromide , chlorphenamine maleate - capsule - formulation: each capsule contains: paracetamol-325mg guaifenesin-50mg phenylpropanolamine hydrochloride-12.5mg dextromethorphan hydrobromide-10mg chlorphenamine maleate-1mg

Kenya - inglise - Pharmacy and Poisons Board

unique pharmaceutical laboratories unique pharmaceutical laboratories - dextromethorphan hydrobromide - lozenge - dextromethorphan hydrobromide 10mg - cough suppressants excluding combinations with

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

seyer pharmatec, inc. - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - guaifenesin 200 mg in 5 ml - uses - helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes. - temporarily relieves cough due to minor throat and bronchial irritations as may occur with the common cold. - temporarily relieves nasal congestions due to the common cold. do not use other information: - warning: phenylketonurics: contains phenylalanine 15 mg per 5 ml - store at 15-30 degree celsius(59-86 degree farenheit) - alcohol free and phenylpropanolamine(ppa) free

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. promethazine products are contraindicated for use in pediatric patients less than two years of age. caution should be exercised when administering promethazine products to pediatric patients 2 years of age and older because of the potential for fatal respiratory depression. respiratory depression and apnea, sometimes associated with death, are strongly associated with promethazine products and are n

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

proficient rx lp - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions,drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. promethazine products are contraindicated for use in pediatric patients less than two years of age. caution should be exercised when administering promethazine products to pediatric patients 2 years of age and older because of the potential for fatal respiratory depression. respiratory depression and apnea, sometimes associated with death, are strongly associated with promethazine products and are no

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

remedyrepack inc. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

par pharmaceutical - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.